Literature DB >> 25060813

SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis.

Martin Hasselblatt1, Inga Nagel, Florian Oyen, Kerstin Bartelheim, Robert B Russell, Ulrich Schüller, Reimar Junckerstorff, Marc Rosenblum, Ali H Alassiri, Sabrina Rossi, Irene Schmid, Nicholas G Gottardo, Helen Toledano, Elisabetta Viscardi, Milagros Balbin, Leora Witkowski, Qianhao Lu, Matthew J Betts, William D Foulkes, Reiner Siebert, Michael C Frühwald, Reinhard Schneppenheim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25060813     DOI： 10.1007/s00401-014-1323-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  50 in total

Review 1.  Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis.

Authors:  Till Holsten; Susanne Bens; Florian Oyen; Karolina Nemes; Martin Hasselblatt; Uwe Kordes; Reiner Siebert; Michael C Frühwald; Reinhard Schneppenheim; Ulrich Schüller
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

2.  Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22.

Authors:  Heather M Byers; Margaret P Adam; Amy LaCroix; Sarah E S Leary; Bonnie Cole; William B Dobyns; Heather C Mefford
Journal:  Am J Med Genet A       Date:  2016-10-12       Impact factor: 2.802

Review 3.  Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies.

Authors:  Michael C Frühwald; Jaclyn A Biegel; Franck Bourdeaut; Charles W M Roberts; Susan N Chi
Journal:  Neuro Oncol       Date:  2016-01-10       Impact factor: 12.300

4.  Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.

Authors:  Emilia M Pinto; Dima Hamideh; Armita Bahrami; Brent A Orr; Tong Lin; Stanley Pounds; Gerard P Zambetti; Alberto S Pappo; Amar Gajjar; Sameer Agnihotri; Alberto Broniscer
Journal:  Acta Neuropathol       Date:  2018-02-10       Impact factor: 17.088

5.  SWI/SNF complex differences promote cellular heterogeneity in rhabdoid tumors.

Authors:  Charles G Eberhart; Jeffrey A Rubens
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

6.  DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control.

Authors:  Helene Kretzmer; Stephan H Bernhart; Wei Wang; Andrea Haake; Marc A Weniger; Anke K Bergmann; Matthew J Betts; Enrique Carrillo-de-Santa-Pau; Gero Doose; Jana Gutwein; Julia Richter; Volker Hovestadt; Bingding Huang; Daniel Rico; Frank Jühling; Julia Kolarova; Qianhao Lu; Christian Otto; Rabea Wagener; Judith Arnolds; Birgit Burkhardt; Alexander Claviez; Hans G Drexler; Sonja Eberth; Roland Eils; Paul Flicek; Siegfried Haas; Michael Humme; Dennis Karsch; Hinrik H D Kerstens; Wolfram Klapper; Markus Kreuz; Chris Lawerenz; Dido Lenzek; Markus Loeffler; Cristina López; Roderick A F MacLeod; Joost H A Martens; Marta Kulis; José Ignacio Martín-Subero; Peter Möller; Inga Nage; Simone Picelli; Inga Vater; Marius Rohde; Philip Rosenstiel; Maciej Rosolowski; Robert B Russell; Markus Schilhabel; Matthias Schlesner; Peter F Stadler; Monika Szczepanowski; Lorenz Trümper; Hendrik G Stunnenberg; Ralf Küppers; Ole Ammerpohl; Peter Lichter; Reiner Siebert; Steve Hoffmann; Bernhard Radlwimmer
Journal:  Nat Genet       Date:  2015-10-05       Impact factor: 38.330

Review 7.  Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors.

Authors:  Miriam Bornhorst; Eugene I Hwang
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

8.  Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.

Authors:  Isabel Tegeder; Katharina Thiel; Serap Erkek; Pascal D Johann; Johannes Berlandi; Venu Thatikonda; Michael C Frühwald; Marcel Kool; Astrid Jeibmann; Martin Hasselblatt
Journal:  J Neurooncol       Date:  2018-11-16       Impact factor: 4.130

9.  The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.

Authors:  Leora Witkowski; Catherine Goudie; Pilar Ramos; Talia Boshari; Jean-Sebastien Brunet; Anthony N Karnezis; Michel Longy; James A Knost; Emmanouil Saloustros; W Glenn McCluggage; Colin J R Stewart; William P D Hendricks; Heather Cunliffe; David G Huntsman; Patricia Pautier; Douglas A Levine; Jeffrey M Trent; Andrew Berchuck; Martin Hasselblatt; William D Foulkes
Journal:  Gynecol Oncol       Date:  2016-03-19       Impact factor: 5.482

10.  SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.

Authors:  X Shi; Q Wang; J Gu; Z Xuan; J I Wu
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.